Login / Signup
Seda Hanife Oğuz
(Seda Hanife Oguz)
ORCID
Publication Activity (10 Years)
Years Active: 2021-2023
Publications (10 Years): 8
Top Topics
Growth Hormone
Ulcerative Colitis
Tyrosine Kinase
Polycystic Ovary Syndrome
Top Venues
Endocrine
Diabetology international
Reviews in endocrine & metabolic disorders
Immunotherapy
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Seda Hanife Oğuz
,
Beyza Seda Boyraz
,
Banu Ertürk
,
Bulent Okan Yildiz
The prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome in treatment-naïve transgender people assigned female at birth.
Endocrine
84 (1) (2023)
Seda Hanife Oğuz
,
Beyza Seda Boyraz
,
Banu Ertürk
,
Bulent Okan Yildiz
The prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome in treatment-naïve transgender people assigned female at birth.
Endocrine
(2023)
Seda Hanife Oğuz
,
Beyza Seda Boyraz
,
Banu Ertürk
,
Bulent Okan Yildiz
The prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome in treatment-naïve transgender people assigned female at birth.
Endocrine
84 (1) (2023)
Bahadir Koylu
,
Busra Firlatan
,
Suleyman Nahit Sendur
,
Seda Hanife Oğuz
,
Selcuk Dagdelen
,
Tomris Erbas
Giant growth hormone-secreting pituitary adenomas from the endocrinologist's perspective.
Endocrine
(2022)
Seda Hanife Oğuz
,
Busra Firlatan
,
Suleyman Nahit Sendur
,
Selcuk Dagdelen
,
Tomris Erbas
Follow, consider, and catch: second primary tumors in acromegaly patients.
Endocrine
(2022)
Tuba Yalçın
,
Seda Hanife Oğuz
,
Miyase Bayraktar
,
Neslişah Rakicioğlu
Anthropometric measurements and serum TNF-α, IL-6 and adiponectin in type 2 diabetes.
Diabetology international
13 (2) (2021)
Seda Hanife Oğuz
,
Ugur Unluturk
,
Sercan Aksoy
,
Tomris Erbas
Clinical course and management of pembrolizumab-associated isolated adrenocorticotrophic hormone deficiency: a new case and literature review.
Immunotherapy
13 (14) (2021)
Seda Hanife Oğuz
,
Meltem Koca
,
Bulent Okan Yildiz
Aging versus youth: Endocrine aspects of vulnerability for COVID-19.
Reviews in endocrine & metabolic disorders
(2021)